Research Commercialization - Lecture 01 - Speaker 01 - Ferguson
-
Upload
epics-qt-collaboration -
Category
Government & Nonprofit
-
view
28 -
download
0
description
Transcript of Research Commercialization - Lecture 01 - Speaker 01 - Ferguson
Why Is Technology
Commercialization So Important
For Scientists?
Steven M. Ferguson
Deputy Director,
Licensing & Entrepreneurship
NIH Office of Technology Transfer
DHHS Email: [email protected]
Technology Commercialization
Programs Provide Many Benefits
• Provides means getting innovative products to the market for public benefit
• Commercial & public recognition of important technologies
• Attracts new R&D resources & partnerships for lab
• Obtains return on investment
• Stimulates economic development
Technology Commercialization: An
Interdisciplinary Field
Scientific Discovery Commercialization
Intellectual
Property or
Patents
Critical Elements of Technology
Commercialization – Transition from
Science to Business
• Scientific Invention
– “Not an occupation for the ELITE” (Kary B. Mullis)
– Inventions are important, but not everything important is an
invention!
• Business Development
– Set realistic goals as early as possible and make progress
toward the goal continuously
– It is a marathon but not a sprint
Discovery
Exploratory Development
Full DevelopmentRegistration
Project Team
and Plans
Project Team
and Plans
Synthesis
of Compounds
Synthesis
of Compounds ScreeningScreening
Studies in Healthy
Volunteers (Phase I)
Studies in Healthy
Volunteers (Phase I)
Early Safety
Studies
Early Safety
Studies
CandidateCandidateFormulations
Developed
Formulations
Developed
Extensive Safety
Studies
Extensive Safety
Studies
NDA/MMANDA/MMA
Studies in 100-300
Patients (Phase II)
Studies in 100-300
Patients (Phase II)
Clinical Data
Analysis
Clinical Data
Analysis
Candidate Medicine Tested in
3-10,000 Patients (Phase III)
Candidate Medicine Tested in
3-10,000 Patients (Phase III)
Large Amounts of
Candidate Medicine
Synthesized
Large Amounts of
Candidate Medicine
Synthesized
Example: The Long Road For New
Biomedicines
Example: The Long Road For New
Biomedicines
Source: Pfizer
The Scientist’s Dilemma
• The invention is only a good start.
• Continuation of development can be problematic.
• Interacting with “companies” is both enlightening and distracting. How can it be done properly?
• Interacting with patent attorneys is enlightening, distracting and can be very frustrating at times
• Continuation into uncharted R&D waters - we can predict everything but the future!
The Scientist’s Basic Obligations For
Successful Commercialization
• Keep accurate lab notebooks - bound lab
notebooks are essential - dated and signed.
• Disclosure - abstracts, meeting talks,
publications online all constitute disclosure, you
risk loss of non-U.S. rights! Beware the
"website trap".
The Scientist’s Basic Obligations For
Successful Commercialization (cont.)
• Work with tech transfer office staff, law firm and commercial partners.
• CDAs/MTAs (Confidential Disclosure Agreements / Material Transfer Agreements) - are essential for the transfer of information and reagents - don’t aim to please interested third parties without first contacting your tech transfer office.
Patenting and Commercializing My
Invention: Is It Worth It?
• Yes, and it’s your job and the job of others.
• The public benefits when new products are
developed.
• Development usually requires patent protection to
enable companies to take necessary financial risks.
• Patent prosecution can always be (and often is)
abandoned - but cannot be (re)started when it’s too
late and disclosures have been made.
Patenting and Commercializing My
Invention: Is It Worth It? (Cont.)
• Won't it interfere with sharing of my reagents? (It
need not!)
• What about the culture of publish or perish? (Can
have both patents & publications!)
TECHNOLOGY TRANSFER
BUSINESS DEVELOPMENT
ATTORNEYS
Scientific
Discovery
Intellectual
Property
Technology
Transfer
Financial
Capital
Corporate
Partnership
R&D
Clinical trials
Regulatory
Manufacturing
Sales &
Marketing
Product Commercialization:
From Lab Bench to Customer
Technology Commercialization at
Universities and Federal Labs
• Lab evaluate inventions for patenting
• Lab works closely with inventors
• Work with law firms and management of patents
• Identify and negotiate with a commercial partner
for license or collaboration agreements
• Managing relationship with commercial partners
Technology Commercialization at
Small Companies
• Management of intellectual properties
• In-license technologies from universities and
research institutes or develop in-house
• Out-license or partner with large companies
• Entrepreneurial focus & opportunity
• High risk firm / high risk technology match
Technology Commercialization at
Large Companies
• Part of a large technology portfolio
• Specialized in larger markets areas
• More in-licensing than out-licensing deals
• More stable commercialization (historically) but
at slower pace
• Tend to work with later stage technologies
Can Commercialization Make Me
Rich As An Inventor?
• Answer - yes and no!
• Academic & Federal labs share license and royalty
payments with individual inventors.
• There are payment caps or restrictions on the level
of commercial involvement at most institutions.
• Largest rewards (and risks!) and level of
involvement come from entrepreneurial activity
separate from the lab.
Scientists As Entrepreneurs
• Scientific knowledge & research alone will not
generate economic prosperity.
• New ideas from research are complex & not
always understood and commercialized by
existing firms.
• Often entrepreneur is needed to facilitate
development of new ideas from research labs.
Scientists As Entrepreneurs (Cont.)
• Entrepreneurship enables investment to seed new
knowledge & a means of harvesting research results.
• Commercialization leads to news firms & industries,
job creation and economic growth.
• “Ivory Tower-only" image of scientists changing.
• Now “local heroes of the global village”.
• Difference between U.S. and many other countries.
Source: Kauffmann Foundation
Why Have Scientists Succeeded In
the U.S. As Entrepreneurs?
• Not due to geographic origin (many not native U.S.).
• More about institution, legal and organizational support for entrepreneurship.
• Bayh-Dole Act seen as stimulus for commercializing federally-funded research in U.S.
• Grants a proven engine for entrepreneurship.
• 25% of NCI grant recipients from 1998-2003 started their own company.
Why Have Scientists Succeeded In The
U.S. As Entrepreneurs? (Cont.)
• SBIR grants foster the kind of research that
translates new science findings into product
opportunities.
• Incubators, technology parks, start-up programs,
entrepreneurial training programs, social networks
all have assisted the process.
Source: Kauffmann Foundation; Washington Post
Growing Entrepreneurial Scientists
· New and emerging companies founded by
scientist/entrepreneurs have driven the development of
innovative products.
· Funding & training scientists (especially at academic
research centers) can provide the next wave of
innovative small companies in the U.S. or elsewhere.
· Business & entrepreneurial training programs can
provide the spark for such developments.
Summary:
Technology Commercialization -- An
Exciting & Important Field For Scientists
• Increasing integrated into program goals of the research enterprise.
• Can increase public impact of your science.
• Institutional staff available to support commercialization of your inventions.
• Highest opportunity for control / reward come from entrepreneurial activity away from the lab.
Acknowledgements
• A very special thanks to Kai Chen, Ph.D., M.B.A.
and David FitzGerald, Ph.D.